Article Text

Download PDFPDF
Original article
Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
  1. Ziad Hijazi1,
  2. Jonas Oldgren1,
  3. Ulrika Andersson2,
  4. Stuart J Connolly3,
  5. Michael D Ezekowitz4,
  6. Stefan H Hohnloser5,
  7. Paul A Reilly6,
  8. Agneta Siegbahn7,
  9. Salim Yusuf3,
  10. Lars Wallentin1
  1. 1Department of Cardiology, Uppsala Clinical Research Center and Department of Medical Sciences, Uppsala University, Uppsala, Sweden
  2. 2Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
  3. 3Population Health Research Institute, Hamilton, Canada
  4. 4Thomas Jefferson Medical College and the Heart Center, Wynnewood, Pennsylvania, USA
  5. 5Department of Cardiology, J. W. Goethe University, Frankfurt, Germany
  6. 6Boehringer Ingelheim Pharmaceuticals, Ridgefield, USA
  7. 7Department of Medical Sciences, Uppsala Clinical Research Center, Clinical Chemistry, Uppsala University, Uppsala, Sweden
  1. Correspondence to Dr Ziad Hijazi, Uppsala Clinical Research Center, Dag Hammarskjölds väg 14B, 1st floor, SE- 752 37 Uppsala, Sweden; Ziad.hijazi{at}ucr.uu.se

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles